3Ambroseh A,Dierkes J,Lobmann R,et al. Hyperhomocysteinemia and endothelial dysfuction in DDM[J].Dinobetes Med, 2001,18 (3):185-192.
二级参考文献12
1Scott CH, Sutton MS. Homocysteine:evidence for a causal relationship with cardiovascular disease[J]. Cardiology in Review,1999,7:101-107.
2Ozmen B, Ozmen D, Turgan N, et al. Associaton between homocysteinemia and renal function in patients with type 2 diabetes mellitus[J]. Ann Clin Lab Sci, 2002,32:279-286.
3Brouwer DAJ, Welten HE, Reijngoud DJ, et al. Plasma folic acid cutoff value,derived from its relationship with homocysteine[J]. Clin Chem, 1998,44:1545-1550.
4Aso Y, Inukai T, Takemura Y. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients:possible application as a marker for vascular endothelial injury[J]. Metabolism, 1998,47:362-365.
5Mc Quillan BM, Beilby JP, Nidorf M, et al. Hyperhomocysteinemia but not the C667T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening[J]. Circulation, 1999,99:2383-2388.
6叶任高.内科学[M]：第5版[M].北京：人民卫生出版社,2001.159.
7Hofmann MA,Kohl B,Zumbach MS,et al.Hyperhomocystinemia and endothelial dysfunction in IDDM.Diabetes Care,1997,20:1880-1886.
